Trends in Mortality from Hemorrhagic Stroke in Korea from 2012 to 2020.

IF 1.2 Q4 CLINICAL NEUROLOGY Neurointervention Pub Date : 2022-07-01 Epub Date: 2022-06-23 DOI:10.5469/neuroint.2022.00220
Kwang-Chun Cho, Hasung Kim, Sang Hyun Suh
{"title":"Trends in Mortality from Hemorrhagic Stroke in Korea from 2012 to 2020.","authors":"Kwang-Chun Cho,&nbsp;Hasung Kim,&nbsp;Sang Hyun Suh","doi":"10.5469/neuroint.2022.00220","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To analyze trends in mortality rates from hemorrhagic stroke (HS) according to HS subtypes, using nationwide data from January 2012 to December 2020.</p><p><strong>Materials and methods: </strong>We used data from the National Health Claims Database provided by the National Health Insurance Service for 2012-2020 using the International Classification of Disease. The age-adjusted mortality rates of HS, which included subarachnoid hemorrhage (SAH) and intracerebral hemorrhage (ICH), were calculated, and additional analyses were conducted according to age and sex.</p><p><strong>Results: </strong>The age-adjusted mortality rates for HS, SAH, and ICH decreased substantially in both sexes between 2012 and 2020. During the study period, mortality rates for HS decreased from 8.87 deaths per 100,000 inhabitants to 6.27 deaths per 100,000 inhabitants. Regarding SAH, mortality rates decreased from 3.72 deaths per 100,000 inhabitants to 2.57 deaths per 100,000 inhabitants. Concerning ICH, mortality rates decreased from 6.91 deaths per 100,000 inhabitants to 4.75 deaths per 100,000 inhabitants. The average annual percentage change for HS, SAH, and ICH was -0.04, -0.04, and -0.05, respectively. Mortality rates from HS, SAH, and ICH in both sexes decreased from 2012 to 2020 in all age groups.</p><p><strong>Conclusion: </strong>In Korea, the age-adjusted mortality rate of HS, SAH, and ICH demonstrated a declining trend in both sexes and across all age groups. These results may aid in the design and improvement of preventive strategies.</p>","PeriodicalId":19140,"journal":{"name":"Neurointervention","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/93/15/neuroint-2022-00220.PMC9256467.pdf","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurointervention","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5469/neuroint.2022.00220","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/6/23 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 2

Abstract

Purpose: To analyze trends in mortality rates from hemorrhagic stroke (HS) according to HS subtypes, using nationwide data from January 2012 to December 2020.

Materials and methods: We used data from the National Health Claims Database provided by the National Health Insurance Service for 2012-2020 using the International Classification of Disease. The age-adjusted mortality rates of HS, which included subarachnoid hemorrhage (SAH) and intracerebral hemorrhage (ICH), were calculated, and additional analyses were conducted according to age and sex.

Results: The age-adjusted mortality rates for HS, SAH, and ICH decreased substantially in both sexes between 2012 and 2020. During the study period, mortality rates for HS decreased from 8.87 deaths per 100,000 inhabitants to 6.27 deaths per 100,000 inhabitants. Regarding SAH, mortality rates decreased from 3.72 deaths per 100,000 inhabitants to 2.57 deaths per 100,000 inhabitants. Concerning ICH, mortality rates decreased from 6.91 deaths per 100,000 inhabitants to 4.75 deaths per 100,000 inhabitants. The average annual percentage change for HS, SAH, and ICH was -0.04, -0.04, and -0.05, respectively. Mortality rates from HS, SAH, and ICH in both sexes decreased from 2012 to 2020 in all age groups.

Conclusion: In Korea, the age-adjusted mortality rate of HS, SAH, and ICH demonstrated a declining trend in both sexes and across all age groups. These results may aid in the design and improvement of preventive strategies.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2012 - 2020年韩国出血性中风死亡率趋势
目的:利用2012年1月至2020年12月的全国数据,分析出血性卒中(HS)亚型的死亡率趋势。材料和方法:我们使用的数据来自2012-2020年国家健康保险服务提供的国家健康索赔数据库,使用国际疾病分类。计算HS的年龄校正死亡率,包括蛛网膜下腔出血(SAH)和脑出血(ICH),并按年龄和性别进行分析。结果:2012年至2020年,HS、SAH和ICH的年龄调整死亡率在两性中均显著下降。在研究期间,HS死亡率从每10万居民8.87例死亡下降到每10万居民6.27例死亡。关于SAH,死亡率从每10万居民3.72人死亡降至每10万居民2.57人死亡。关于非流行性脑炎,死亡率从每10万居民6.91人死亡下降到每10万居民4.75人死亡。HS、SAH和ICH的年平均变化百分比分别为-0.04、-0.04和-0.05。从2012年到2020年,所有年龄组的HS、SAH和ICH的死亡率在两性中都有所下降。结论:在韩国,HS、SAH和ICH的年龄调整死亡率在两性和所有年龄组中均呈下降趋势。这些结果可能有助于设计和改进预防战略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.80
自引率
0.00%
发文量
34
审稿时长
12 weeks
期刊最新文献
First-Line Aspiration Thrombectomy of M2 Occlusions with a Novel Reperfusion Catheter (REDTM 62): Real-World Experience from Two Tertiary Comprehensive Stroke Centers. Coil Embolization of a Ruptured Anterior Spinal Artery Aneurysm Associated with Spinal Cord Arteriovenous Malformation. Delayed Pontomesencephalic and Cervical Cord Venous Drainage Followed by Contralateral Carotid-Cavernous Fistula after Craniofacial Fractures: A Case Report. Endovascular Treatment of Scalp Arteriovenous Fistula: Transvenous Onyx Embolization with Balloon Occlusion. Efficacy of Endovascular Glue Embolization in Treating Ruptured Intracranial Mycotic Aneurysms: A Single Center Experience.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1